Drug repositioning: Auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections

BioMetals

Volumn 27, Issue 4, 2014, Pages 787-791

  Cassetta, Maria Iris ^a   Marzo, Tiziano ^a   Fallani, Stefania ^a   Novelli, Andrea ^a   Messori, Luigi ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Antimicrobial drugs; Auranofin; Drug repositioning; Gold compounds; Staphyloccocal infections

Indexed keywords

ANTIINFECTIVE AGENT; AURANOFIN;

DRUG EFFECTS; DRUG REPOSITIONING; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TEST; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; AURANOFIN; DRUG REPOSITIONING; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS;

EID: 84905106644     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9743-6     Document Type: Article

References (19)

1. Aroson JK (2007) Old drugs - new uses. Br J Clin Pharmacol 64:563-565
2. Bondenson J (1997) The mechanisms of action of disease-modifying antirheumatic drugs: a review with emphasis on macrophage signal transduction and the induction of pro-inflammatory cytokines. Gen Pharmacol 29:127-150
3. Cavalla D (2013) Predictive methods in drug repurposing: gold mine or just a bigger haystack? Drug Discov Today 18:523-532
4. Chong CR, Sullivan DJ (2007) New uses for old drugs. Nature 448:645-646 (Pubitemid 47236844)
5. Clinical Laboratory Standards Institute (CLSI) (2004), National Committee for Clinical Laboratory Standard, Performance Standards for Antimicrobial Susceptibility Testing; Fourteenth International Supplement M100-S14, NCCLS, Wayne, PA, USA
6. Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26:1-10
7. Han S, Kim K, Kim H, Kwon J, Lee YH, Lee CK, Song Y, Ha Lee N, Kim K (2008) Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages. Arch Pharm Res 31:67-74
8. Jackson-Rosario SE, Self WT (2009) Inhibition of selenium metabolism in the oral pathogen Treponema denticola. J Bacteriol 191:4035-4040
9. Jackson-Rosario SE, Self WT (2010) Targeting selenium metabolism and selenoproteins: novel avenues for drug discovery. Metallomics 2:112-116
10. Jackson-Rosario SE, Cowarte D, Myers A, Tarrien R, Rodney LL, Scott RA, Self WT (2009) Auranofin disrupts selenium metabolism in Clostridium difficile by forming a stable Au-Se adduct. JBIC 14:507-510
11. Karampela I, Poulakou G, Dimopoulus G (2012) Community acquired methicillin resistant Staphylococcus aureus pneumonia: an update for the emergency and intensive care physician. Minerva Anestesiol 78:930-940
12. Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arnér ES, Williams DL (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLOS Med 4:1071-1086 (Pubitemid 46998624)
13. Madeira JM, Gibson DL, Kean WF, Klegeris A (2012) The biological activity of auranofin: implications for novel treatment of diseases. Inflammopharmacology 20:297-306
14. Messori L, Marcon G (2004) Gold complexes in the treatment of rheumatoid arthritis. Met Ions Biol Syst 41:279-304
15. Novelli F, Recine M, Sparatore F, Juliano C (1999) Gold(I) complexes as antimicrobial agents. Il Farmaco 54:232-236 (Pubitemid 29259826)
16. Sanella AR, Casini A, Gabbiani C, Messori L, Bilia AR, Vincieri FF, Majori G, Severini C (2008) New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: mechanistic and pharmacological implications. FEBS Lett 582:844-847
17. Shaw F (1999) Gold-based therapeutic agents. Chem Rev 99:2589-2600
18. Tejman-Yarden N, Miyamoto Y, Leitsch D, Santini J, Debnath A, Gut J, McKerrow JH, Reed SL, Eckmann L (2013) A reprofiled drug, auranofin, is effective against metronidazole-resistant Giardia lamblia. Antimicrob Agents Chemother 57:2029-2035
19. Zou J, Taylor P, Dornan J, Robinson SP, Walkinshaw MD, Sadler PJ (2000) First crystal structure of a medicinally relevant gold protein complex: unexpected binding of [Au(PEt3)]+ to histidine. Angew Chem 39:2931-2934 (Pubitemid 30663828)